The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more.  The ability to track those samples though this ecosystem with full visibility for the sponsor is essential for a successful trial. In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, describes that ecosystem and the lifecycle of patient samples. 

 

She describes:

• The varying approaches of small vs. large laboratories



• Risks of insufficient tracking



• Tracking consent for future use



• Current practice and opportunities for improved tracking

Learn more at https://www.q2labsolutions.com/labmatrix